FAQs–Application of OIG's Administrative Enforcement Authorities to Arrangements Directly Connected to the Coronavirus Disease 2019 (COVID-19) Public Health Emergency
This FAQ addresses the Federal anti-kickback statute and beneficiary inducements CMP implications of rewards and incentives offered to Federal health care program beneficiaries in connection with receiving the COVID-19 vaccine.
Issued by: Office of Inspector General (OIG)
Issue Date: May 24, 2021
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.